Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study

被引:0
|
作者
Han Eol Jeong
Sohee Park
Yunha Noh
Sungho Bea
Kristian B. Filion
Oriana H. Y. Yu
Seung Hun Jang
Young Min Cho
Dong Keon Yon
Ju-Young Shin
机构
[1] Sungkyunkwan University,School of Pharmacy
[2] Sungkyunkwan University,Department of Biohealth Regulatory Science
[3] Biostatistics,Departments of Medicine and of Epidemiology
[4] and Occupational Health,Centre for Clinical Epidemiology
[5] McGill University,Division of Endocrinology and Metabolism
[6] Lady Davis Institute,Division of Pulmonary, Allergy, and Critical Care Medicine, College of Medicine
[7] Jewish General Hospital,Department of Internal Medicine
[8] Jewish General Hospital,Department of Translational Medicine
[9] McGill University,Department of Internal Medicine
[10] Hallym University Sacred Heart Hospital,Institute On Aging
[11] Hallym University,Department of Pediatrics
[12] Seoul National University College of Medicine,Department of Clinical Research Design & Evaluation, Samsung Advanced Institute for Health Sciences & Technology (SAIHST)
[13] Seoul National University College of Medicine,undefined
[14] Seoul National University Hospital,undefined
[15] Seoul National University,undefined
[16] Medical Science Research Institute,undefined
[17] Kyung Hee University College of Medicine,undefined
[18] Kyung Hee University Medical Center,undefined
[19] Kyung Hee University College of Medicine,undefined
[20] Sungkyunkwan University,undefined
来源
BMC Medicine | / 21卷
关键词
Sodium-glucose cotransporter 2 inhibitors; Respiratory effectiveness; Type 2 diabetes; Population-based cohort;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 2 条
  • [1] Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study
    Jeong, Han Eol
    Park, Sohee
    Noh, Yunha
    Bea, Sungho
    Filion, Kristian B.
    Yu, Oriana H. Y.
    Jang, Seung Hun
    Cho, Young Min
    Yon, Dong Keon
    Shin, Ju-Young
    BMC MEDICINE, 2023, 21 (01)
  • [2] Influence of early use of sodium-glucose transport protein 2 inhibitors, glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors on the legacy effect of hyperglycemia
    Deng, Siwei
    Zhao, Houyu
    Chai, Sanbao
    Sun, Yexiang
    Shen, Peng
    Lin, Hongbo
    Zhan, Siyan
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15